John Glenn - Jun 20, 2023 Form 4 Insider Report for IRADIMED CORP (IRMD)

Role: CHIEF FINANCIAL OFFICER
Signature: /s/ John Glenn
Stock symbol: IRMD
Transactions as of: Jun 20, 2023
Transactions value $: -$67,607
Form type: 4
Date filed: 6/22/2023, 04:30 PM
Previous filing: Dec 16, 2022
Next filing: Dec 11, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IRMD	Common Stock	Options Exercise		+5.8K	+231.8%		8.3K	Jun 20, 2023	Direct	F1
transaction	IRMD	Common Stock	Tax liability	-$67.6K	-1.41K	-17.02%	$47.88	6.88K	Jun 20, 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IRMD	Restricted Stock Units	Options Exercise	$0	-5.8K	-25%	$0.00	17.4K	Jun 20, 2023	Common Stock	5.8K		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert into common stock on a one-for-one basis.
F2	On June 20, 2022, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on June 20, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.